Evolution of the Average Target: Roche Holding AG

Evolution of the Target Price: Roche Holding AG

Changes in Analyst Recommendations: Roche Holding AG

8c2a24dce1644773.DzOm293W6XngdZ1ESy28Ml91hSpc9pN9mvCGKxDGSA0.XnXItbOhhCaBPK98HViJQRkPqHMLptsz66_DTVOUHWRgVNW9iqGeEtQ30A~ff31bec514714758bbd677ee91fe4a52
07-24 ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ZD
07-24 Berenberg Lifts Roche Price Target Amid Upcoming Catalysts MT
07-23 Roche Holding: Good Q2; late-stage pipeline execution key to sustained re-rating Alphavalue
07-23 ROCHE HOLDINGS AG : Bernstein gives a Buy rating ZD
07-23 Swiss stocks - Factors to watch on July 23 RE
07-20 Wall Street's Patience Runs Thin Zonebourse
07-20 Could AI chip boom make ASML Europe's first trillion-dollar firm? RE
07-15 Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns MT
07-14 Where would AI lead Pharma in the long run? Alphavalue
07-06 HSBC Downgrades Roche to Hold Rating MT
06-30 ROCHE HOLDINGS AG : Goldman Sachs sticks Neutral ZD
06-15 Swiss stocks - Factors to watch on June 15 RE
06-11 Wolfe Downgrades Zealand Pharma Following Weak Tolerability Data for Obesity Drug FW
06-08 ROCHE HOLDINGS AG : Jefferies keeps a Sell rating ZD
06-04 Roche in the Red as Jefferies Maintains Underperform Rating Zonebourse
06-04 ROCHE HOLDINGS AG : Receives a Sell rating from Jefferies ZD
05-27 ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ZD
05-26 ROCHE HOLDINGS AG : Barclays reaffirms its Buy rating ZD
05-22 BofA Ups EPS Estimates for AstraZeneca Ahead of 'Busy' Pipeline; Buy Rating Kept MT
05-04 ROCHE HOLDINGS AG : Jefferies reiterates its Sell rating ZD
05-01 ROCHE HOLDINGS AG : JP Morgan reaffirms its Neutral rating ZD
04-28 ROCHE HOLDINGS AG : Buy rating from Barclays ZD
04-27 UBS Raises Its Price Target on Roche Zonebourse
04-27 ROCHE HOLDINGS AG : Bernstein gives a Buy rating ZD
04-24 ROCHE HOLDINGS AG : UBS reiterates its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+6.22%
+2.73%
+3.25%
-1.09%
+25.51%
-1.06%
-5.15%
+21.81%
+17.15%
Average +7.71%
Weighted average by Cap. +6.07%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
355.10CHF
Average target price
361.72CHF
Spread / Average Target
+1.86%
High Price Target
428.00CHF
Spread / Highest target
+20.53%
Low Price Target
230.00CHF
Spread / Lowest Target
-35.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Abhishek Raval
BERNSTEIN RESEARCH Justin Smith
HSBC
GOLDMAN SACHS James Quigley
JEFFERIES Michael Leuchten
BARCLAYS James Gordon
JPMORGAN Richard Vosser
UBS Matthew Weston
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
355.10CHF
Average target price
361.72CHF
Spread / Average Target
+1.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ROP Stock
  4. 0QOK Stock
  5. Consensus Roche Holding AG